Advice
Do you know a person with dementia or memory problems who is refusing offers of help? Here are a few ways to support someone who may be in denial or lack insight about their situation.
Advice
The main difference between Alzheimer’s and dementia is that Alzheimer’s is a disease in the brain, whereas dementia is a collection of symptoms. Alzheimer’s disease causes cognitive decline, eventually leading to dementia. It’s the most common reason why people get dementia.
Research

Donanemab has been licensed in the UK as a treatment for early-stage Alzheimer’s but is only available privately, not through the NHS. Here's what we know about this new Alzheimer's drug.

Real stories

Husband and wife, George and Tencie share how they spotted the first signs of Alzheimer's disease and why it's important to ignore cultural stigma around getting a dementia diagnosis.

Information

Party conference season is a prime opportunity for Alzheimer’s Society to meet with key decision makers and put our calls front and centre of the political landscape.

Research

Lecanemab made headlines as the first MHRA-approved drug in the UK to slow early-stage Alzheimer’s disease, but it has not been recommended for use on the NHS. Here is what we know so far about this breakthrough Alzheimer's drug. 

Real stories

Both of Sania Rehman’s grandfathers had dementia, but their experiences were very different. After a career in IT, she has now become a Local Services Manager for Team Sahara (meaning ‘support’ in Urdu) who assist South Asian families to access culturally appropriate help.

Research
Artificial intelligence technology could be a game-changer for people affected by dementia. Find out why Alzheimer’s Society is supporting research in this area.
Real stories

Organised by the Premier League and the Professional Footballers’ Association (PFA), representatives from 16 Premier League and English Football League clubs and their charitable foundations came together at the Developing Dementia Initiatives workshop at Premier League headquarters in London.

Research
Guest blogger, Professor Karen Watchman, explores the myths surrounding Down's syndrome and dementia.
Information

We are thrilled to announce two exciting new partnerships through our Alzheimer’s Society Accelerator Programme, designed to support innovative dementia products and bring help and hope to people living with dementia. These collaborations mark significant steps in our ongoing mission to improve the lives of those affected by dementia.